Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Notice of Testim Discontinuation

The manufacturer of Testim® has advised that it intends to cease production and supply of this product in 2018.

The product is currently out of stock but supplies are expected to be delivered in early 2018, currently estimated as February. However, once this delivery of stock has been made it seems the product will be discontinued with no further supplies being made. The manufacturer stresses that the decisions to discontinue this product is not due to issues regarding safety, quality or efficacy of the product.

Testim® contains 50 mg of testosterone in a 5g unit dose container. Testogel® would appear to be a reasonable replacement; it contains the same strength of testosterone in the same unit dose presentation.

Action: Clinicians should be aware of this product being discontinued. It would be prudent to run clinical system searches to identify any patients who are currently prescribed this product to allow suitable alternatives to be arranged.

Share 'Notice of Testim Discontinuation' on Email Share 'Notice of Testim Discontinuation' on Delicious Share 'Notice of Testim Discontinuation' on Digg Share 'Notice of Testim Discontinuation' on Facebook Share 'Notice of Testim Discontinuation' on Google+ Share 'Notice of Testim Discontinuation' on reddit Share 'Notice of Testim Discontinuation' on StumbleUpon Share 'Notice of Testim Discontinuation' on Twitter

atomic-wealth

No Comments to “Notice of Testim Discontinuation”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,952 spam comments.

atomic-wealth
fond-illness
summer